The IOLMaster 700 is intended for biometric measurements and visualization of ocular structures. The measurements and visualization assist in the determination of the appropriate power and type of intraocular lens. The IOLMaster 700 measures:

· Lens thickness
· Corneal curvature and thickness
· Axial length
· Anterior chamber depth
· Pupil diameter
· White-to-white distance (WTW)

For visualization, the IOLMaster 700 employs optical coherence tomography (OCT) to obtain two-dimensional images of ocular structures of the anterior and posterior segments of the eye.

The Reference Image functionality is intended for use as a preoperative image capture tool.

Device Description

The IOLMaster 700 is a non-invasive optical biometry instrument for visualization and measurement of ocular structures. The IOLMaster 700 is the latest generation device in the IOLMaster series. The version of the IOLMaster 700 that is the subject of this submission is a modified version of the IOLMaster 700 cleared under K143275.

The differences between the subject IOLMaster 700 and the predicate IOLMaster 700 that are the subject of this 510(k) submission are:

. Labeling changes, including inclusion of additional clinical data and minor updates;
Materials changes to the forehead rest and chin rest ●

The changes described in this submission do not affect how the hardware is used to acquire images, nor do these changes affect the principle of operation of the device.

AI/ML Overview

The provided text is a 510(k) summary for the Carl Zeiss Meditec AG IOLMaster 700 device (K170171). It details a filing for a modified version of an already cleared device (K143275). The modifications are specifically listed as:

Labeling changes, including inclusion of additional clinical data and minor updates.
Materials changes to the forehead rest and chin rest.

The document explicitly states that "The changes described in this submission do not affect how the hardware is used to acquire images, nor do these changes affect the principle of operation of the device." This means that performance data related to the core biometric measurements (Lens thickness, Corneal curvature and thickness, Axial length, Anterior chamber depth, Pupil diameter, White-to-white distance, and OCT visualization) is not included as new testing for this specific 510(k) submission (K170171). The substantial equivalence is based on the new version having identical indications for use and principle of operation to the predicate device, with new testing focused on the biocompatibility and electrical safety of the material changes.

Therefore, many of the requested details, such as specific acceptance criteria for biometric performance, sample sizes for test sets, expert qualifications, ground truth establishment for the test set, MRMC studies, or standalone algorithm performance, are not applicable to this particular 510(k) submission (K170171) because the core performance of the device's measurement capabilities was not re-evaluated. The acceptance criteria and studies described here relate to the changes made to the device.

Here's a breakdown of what is provided and what is not provided in the text based on your request:

Acceptance Criteria and Reported Device Performance

Given that this 510(k) is for minor modifications (labeling and material changes) to an already cleared device with identical indications for use and principle of operation, the "acceptance criteria" discussed are primarily related to safety and maintainance of equivalence.

Acceptance Criteria Category	Specific Criteria (Implicit/Explicit)	Reported Device Performance/Compliance
Biocompatibility	New materials (forehead rest, chin rest) must be biocompatible for patient contact. Compliance with ISO 10993-10:2014 (skin irritation and sensitization) and ISO 10993-5:2009 (cytotoxicity).	"Testing demonstrated that the new materials are biocompatible for the proposed use."
Electrical Safety	Device must comply with electrical safety standards. Specifically, Edition 3.1 of IEC 60601-1 (IEC 60601-1:2005 + Amendment 1 (2012)), Edition 3.1 of IEC 60601-1-6 (IEC 60601-1-6:2010 + Amendment 1 (2013)), and Edition 1.1 of IEC 62366 (IEC 62366:2007 + Amendment 1 (2014)).	"The IOLMaster 700 was evaluated against the requirements of Edition 3.1 of IEC 60601-1 (...), Edition 3.1 of IEC 60601-1-6 (...), and Edition 1.1 of IEC 62366 (...), and found to comply."
EMC (Electromagnetic Compatibility)	Device must comply with EMC standards. Specifically, Edition 4.0 of IEC 60601-1-2 (IEC 60601-1-2:2014).	"The IOLMaster 700 was evaluated against the requirements of Edition 4.0 of IEC 60601-1-2 (...) and found to comply."
Performance (Functional Equivalence)	The changes (labeling, materials) must not affect how the hardware is used to acquire images or the principle of operation, ensuring previous performance characteristics are maintained. This is implied by the "substantial equivalence" claim.	"The changes described in this submission do not affect how the hardware is used to acquire images, nor do these changes affect the principle of operation of the device." The device maintains identical Indications for Use and Principle of Operation as the predicate.
Environmental Conditions	The device's specified ambient conditions for intended use, storage, and transport should be appropriate and maintained or improved compared to the predicate.	Minor changes noted for ambient conditions for intended use (relative humidity range change from 30%-90% to 30%-80%) and storage/transport (more detailed ranges provided for predicate, broader for proposed). The document implies these are considered acceptable to maintain equivalence for the specific modifications.

Study Details for K170171 (Focus on Modifications)

Sample sizes used for the test set and the data provenance:
- For Biocompatibility: The text doesn't specify sample sizes (e.g., number of material samples or animal tests) for the biocompatibility testing (ISO 10993-10, ISO 10993-5). The data provenance is not specified (e.g., country, retrospective/prospective).
- For Electrical Safety & EMC: These are compliance tests (pass/fail) against standards, not typically associated with "sample sizes" in the clinical data sense. A representative device unit would be tested.
- For core biometric performance: No new test set data is provided or relied upon for this specific 510(k) submission (K170171) because the core measurements and principle of operation were not changed.
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable for a 510(k) focused on material and labeling changes. The biocompatibility, electrical safety, and EMC tests rely on established laboratory standards and test methods, not expert consensus on image interpretation.
- For the original clearance of the device (K143275), clinical studies would have been performed, which might have involved experts, but those details are not provided in this summary.
Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- Not applicable as the testing described doesn't involve subjective interpretation that would require an adjudication process.
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable. The IOLMaster 700 is a biometric measurement device and imaging tool, not an AI-assisted diagnostic device. Its function is to provide objective measurements and images for human clinicians to use. This 510(k) in particular focuses on minor physical changes.
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- The IOLMaster 700 is a measurement device. Its "algorithm" is for biometric measurement (e.g., calculating axial length, lens thickness from OCT data). The output itself is a measurement or an image, not a diagnostic interpretation. The device's performance stands alone in its ability to accurately measure. No new standalone performance evaluation was required for the changes in K170171 beyond demonstrating that the material changes did not affect existing performance characteristics.
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- For Biocompatibility: Ground truth is established by the specified ISO standards for cytotoxicity, skin irritation, and sensitization. These tests have defined endpoints (e.g., cell viability, irritation scores).
- For Electrical Safety & EMC: Ground truth is defined by the compliance criteria within the IEC standards themselves.
- For core biometric performance: While not detailed in this summary, the ground truth for biometric measurements (like axial length or corneal curvature) in the original device clearance (K143275) would typically involve comparison to established reference methods or highly accurate clinical gold standards (e.g., pachymetry for corneal thickness, A-scan ultrasonography for axial length, or phakometry for lens thickness, depending on the specific measurement). The document implies that the performance characteristics and measurements produced are identical to the predicate.
The sample size for the training set:
- Not applicable. This device is not an AI/machine learning model that undergoes a "training" phase. Its measurement algorithms are based on optical principles and engineering.
How the ground truth for the training set was established:
- Not applicable (see point 7).

In summary, the K170171 submission focuses on demonstrating substantial equivalence for minor modifications (labeling and materials) to an already cleared device. Therefore, the acceptance criteria and supporting studies are centered on ensuring these specific changes do not negatively impact safety or the previously established performance characteristics, rather than re-evaluating the foundational biometric measurement capabilities.

Summary

{0}------------------------------------------------

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 6, 2017

Carl Zeiss Meditec Ag % Mr. Rahul Ram Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 Alexandria, VA 22314

Re: K170171

Trade/Device Name: IOLMaster 700 Regulation Number: 21 CFR 886.1850 Regulation Name: AC-Powered Slitlamp Biomicroscope Regulatory Class: Class II Product Code: HJO Dated: January 18, 2017 Received: January 19, 2017

Dear Mr. Ram:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

You must comply with all the Act's requirements, including, but not limited to: registration and listing

(21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

Denise L. Hampton -S

for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose, and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K170171

Device Name IOLMaster 700

Indications for Use (Describe)

· Lens thickness
· Corneal curvature and thickness
· Axial length
· Anterior chamber depth
· Pupil diameter
· White-to-white distance (WTW)

For visualization, the IOLMaster 700 employs optical coherence tomography (OCT) to obtain two-dimensional images of ocular structures of the anterior and posterior segments of the eye.

The Reference Image functionality is intended for use as a preoperative image capture tool.

Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(K) SUMMARY

In accordance with 21 CFR 807.87(h) and (21 CFR 807.92) the 510(k) Summary for the IOLMASTER 700 is provided below.

Device Common Name:	Biometer
Device Trade Name:	IOLMASTER 700
Applicant:	Carl Zeiss Meditec AGGoeschwitzer Strasse 51-52D-07745 JenaGermany
Contact:	Dr. Christian MuensterDirector Regulatory and Clinical Affairs+49 7364 206985christian.muenster@zeiss.com
Prepared by:	Rahul RamBiologics Consulting Grouprram@biologicsconsulting.com(571) 777-9518
Date Prepared:	April 5, 2017
Classification Regulation:	21 CFR 886.1850, Class II, AC-powered slitlampbiomicroscope
Panel:	Ophthalmology
Product Code:	HJO - AC-powered slitlamp biomicroscope.
Predicate Device:	Carl Zeiss Meditec AG IOLMASTER 700K143275Product Code: HJO - AC-powered slitlamp biomicroscope.

Indications for Use:

The indications for use are identical between the subject and predicate IOLMaster 700 devices.

{4}------------------------------------------------

. Lens thickness
Corneal curvature and thickness
Axial length
Anterior chamber depth ●
Pupil diameter ●
White-to-white distance (WTW)

For visualization, the IOLMaster 700 employs optical coherence tomography (OCT) to obtain two-dimensional images of ocular structures of the anterior and posterior segments of the eye.

The Reference Image functionality is intended for use as a preoperative and postoperative image capture tool.

Device Description:

The differences between the subject IOLMaster 700 and the predicate IOLMaster 700 that are the subject of this 510(k) submission are:

. Labeling changes, including inclusion of additional clinical data and minor updates;
Materials changes to the forehead rest and chin rest ●

The changes described in this submission do not affect how the hardware is used to acquire images, nor do these changes affect the principle of operation of the device.

Electrical Safety & Electromagnetic Compatibility:

The IOLMaster 700 was evaluated against the requirements of Edition 3.1 of IEC 60601-1 (IEC 60601-1:2005 + Amendment 1 (2012)), Edition 3.1 of IEC 60601-1-6 (IEC 60601-1-6:2010 + Amendment 1 (2013)) and Edition 1.1 of IEC 62366 (IEC 62366:2007 + Amendment 1 (2014)), and found to comply.

The IOLMaster 700 was evaluated against the requirements of Edition 4.0 of IEC 60601-1-2 (IEC 60601-1-2:2014) and found to comply.

Biocompatibility:

Testing was conducted as per the following biocompatibility standards:

ISO 10993-10:2014 (skin irritation and sensitization) ●
. ISO 10993-5:2009 (cytotoxicity)

Testing demonstrated that the new materials are biocompatible for the proposed use.

{5}------------------------------------------------

Device Comparison Table:

DEVICE CHARACTERISTICS	PROPOSED IOLMASTER 700(CARL ZEISS MEDITEC AG)K170171	PREDICATE IOLMASTER 700(CARL ZEISS MEDITEC AG)K143275
Indications for Use	The IOLMaster 700 is intended forbiometric measurements andvisualization of ocular structures. Themeasurements and visualization assist inthe determination of the appropriatepower and type of intraocular lens. TheIOLMaster 700 measures:Lens thickness●Corneal curvature and thickness●Axial length●Anterior chamber depth●Pupil diameter●White-to-white distance (WTW)●For visualization, the IOLMaster 700employs optical coherence tomography(OCT) to obtain two-dimensional imagesof ocular structures of the anterior andposterior segments of the eye.The Reference Image functionality isintended for use as a preoperative andpostoperative image capture tool.	Identical
Principles of Operation	Spectral domain interferometry (OCTprinciple),Light spot projection (infrared LEDs),Image capturing	Identical
Feature - Corneal Curvature Measurement (KER):
Technology for obtainingmeasurements/images	Telecentric keratometry = distanceindependent,Light spot projection (infrared LEDs)	Identical
Keratometry algorithm		Similar
Feature - Lens Thickness Measurement (LT):
Technology for obtainingmeasurements/images	Swept source laserSpectral domain interferometry (OCTprinciple),Multiple A-scans provide a B-scan	Identical

{6}------------------------------------------------

DEVICE CHARACTERISTICS	PROPOSED IOLMASTER 700(CARL ZEISS MEDITEC AG)	PREDICATE IOLMASTER 700(CARL ZEISS MEDITEC AG)K143275
Feature - Central Corneal Thickness Measurement (CCT):
Technology for obtainingmeasurement	Swept source laserSpectral domain interferometry (OCTprinciple),Multiple A-scans provide a B-scan	Identical
Feature - Anterior Chamber Depth Measurement (ACD):
Technology for obtainingmeasurement	Swept source laserSpectral domain interferometry (OCTprinciple),Multiple A-scans provide a B-scan	Identical
Feature - Axial Length Measurement (AL):
Technology for obtainingmeasurement	Swept source laser 1055 nm.Spectral domain interferometry (OCTprinciple),Multiple A-scans provide a B-scan	Identical
Feature - Pupil Diameter Measurement (P):
Technology for obtainingmeasurement	Image capturing of the iris with internaldigital camera.	Identical
Feature - White-to-White Measurement (WTW):
Technology for obtainingmeasurement	Image capturing of the iris with internaldigital camera.	Identical
Feature - Reference Image Functionality:
Technology for obtainingmeasurement	Green LEDs for green light illuminationfor image capturing of scleral vesselswith internal digital camera.	Identical
Feature - Computationalformulas	Haigis suite (includes Haigis, Haigis-Land Haigis-T);Hoffer Q;Holladay 2;SRK®/T	Identical
Electrical Data:
Rated voltage / frequency	100 V to 240 V AC (± 10 %) / 50/60 Hz	Identical
Power consumption:Basic unitIn standby mode	150 W1 W	Identical

{7}------------------------------------------------

Ambient conditions:
for intended use	Temperature: 10°C to +35°C,Relative humidity: 30% to 80%(noncondensing)	Temperature: 10°C to +35°C,Relative humidity: 30% to 90%(noncondensing)
for storage and transport	Temperature: -20°C to +60°C,Relative humidity: 10% to 90%(noncondensing)	for storage:Temperature: -10°C to +55°C,Relative humidity: 10% to 95%(noncondensing)for storage and transport:Temperature: -40°C to +70°C,Relative humidity: 10% to 95%(noncondensing)
Material composition of patientinterface with forehead restand chin rest cap	ABS	PC/ABS Blend

Substantial Equivalence Summary:

Given the acceptable results of performance testing for the significant device modifications, we believe that the subject IOLMaster 700 is substantially equivalent to the predicate IOLMaster 700, cleared under K143275.

Regulation Number and Section

§ 886.1850 AC-powered slitlamp biomicroscope.

(a)
Identification. An AC-powered slitlamp biomicroscope is an AC-powered device that is a microscope intended for use in eye examination that projects into a patient's eye through a control diaphragm a thin, intense beam of light.(b)
Classification. Class II (special controls). The device, when it is intended only for the visual examination of the anterior segment of the eye, is classified as Group 1 per FDA-recognized consensus standard ANSI Z80.36, does not provide any quantitative output, and is not intended for screening or automated diagnostic indications, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.